A shadow market for unapproved slimming drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, according to recent findings.
Investigational Drug Gaining Traction Via Social Media
Retatrutide, which is still in clinical trials, is being promoted by online personalities for its supposed weight-reducing properties. Followers are urged to contact these accounts directly for source information, while also obtaining promotional offers.
Active Trade on Messaging Platforms
Separately, a flourishing market exists on messaging services, where groups with numerous of members share “before and after” photos, injection guides and claims of rapid British shipping. Vendors promote the substance there before directing customers to other platforms for purchases.
Understanding Retatrutide
Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could help patients reduce up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted digitally as the next Ozempic.
Medical Professionals Voice Worries
Nevertheless, doctors and pharmacists have cautions that the sale of what is still an unapproved drug in the United Kingdom is worrisome and could result in individuals administering products of unknown origin.
Several experts stated the demand for retatrutide could be linked to the rising price of approved weight loss products such as Mounjaro.
Legal Status and Enforcement
Marketing retatrutide on social media or messaging apps is illegal in the United Kingdom, as it is an unapproved drug that cannot be marketed or supplied for personal consumption under the British medical regulations.
Several content creators try to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still breach medicines, advertising, and consumer regulations, potentially leading to penalties, prosecution or prison.
Platform Response and Content Elimination
According to TikTok, the service has removed violative content and banned related keywords and search suggestions. The company stated it was dedicated to maintaining the platform secure and allocating resources in enhancing enforcement strategies.
Digital Marketplace Activities
Research also found communities with up to 9,000 participants selling the experimental drug using the platform's integrated search feature, which functions like a public directory. Entering “retatrutide” immediately brings up channels with thousands of members, filled with images of weight loss, glowing reviews and detailed guides for preparing or administering at home.
After moments of joining one community, a seller shared contact information, where the majority of purchases occur. The seller sent an guidebook and guaranteed shipping within 48 hours. When asked whether the substance was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. None inquired about weight, health issues or previous experience.
Item Information and Costs
Inside these communities, messages show black plastic packages with postal service labels, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”
Buyers can select between powder vials, mixed at home with purified liquid, or ready-to-use pens typically priced at £160 for 20mg. When questioned how long a pen should last, vendors give contradictory responses varying between a few weeks to “depends on your body”.
Service Moderation and Security Actions
A representative for the messaging service stated it regularly monitored harmful content on its platform including content that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“People are administering materials they cannot confirm. Even if the science behind this drug is sound, these digital versions may not include what they claim,” said Jason Murphy, the head of pharmacy at a pharmacy service.
Dr Crystal Wyllie of an online medical service linked the surge in interest to current price rises for approved weight-loss medications such as Mounjaro. “With prices increasing, individuals are turning to social media. But counterfeit injections are highly risky. You cannot know what’s inside or whether the conditions they were produced in was clean,” she said.
Her team has already encountered patients harmed by self-injection from unconfirmed suppliers. “We understand the frustration, but purchasing from Telegram or WhatsApp is gambling with your well-being,” stated the doctor. “These materials could be contaminated or incorrectly dosed.”
Manufacturer Position
A spokesperson from Eli Lilly stated the substance was in third stage clinical trials and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Therefore at this point no one can sell [it] for personal consumption,” they said, adding that any product “falsely representing itself as a Lilly experimental substance not yet approved … may subject users to possibly serious health risks”.
